<DOC>
	<DOCNO>NCT01279356</DOCNO>
	<brief_summary>Liver diseases non-alcoholic fatty liver disease ( NAFLD ) , alcoholic liver disease ( ALD ) viral hepatitis potential progress cirrhosis finally hepatocellular carcinoma ( HCC ) . Early diagnosis treatment liver diseases important since progression likely associate significant morbidity mortality . However , daily clinical practice specific non-invasive biomarkers use diagnosis follow-up patient liver disease . It known patient liver disease produce compound excrete breath consequence metabolic process , inflammation and/or oxidative stress . These call volatile organic compound ( VOCs ) . Analysis VOCs exhale air report provide valuable information patient chronic obstructive lung disease ( COPD ) inflammatory bowel disease ( IBD ) . Also , patient liver disease , exhale VOCs detect . The investigator hypothesize analysis VOCs exhale air patient liver disease use diagnosis follow-up .</brief_summary>
	<brief_title>Volatile Organic Compounds ( VOCs ) Liver Diseases</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>Established diagnosis liver disease base laboratory , radiological histological characteristic Age 18 85 year Inflammatory bowel disease Chronic obstructive lung disease , lung cancer , asthma Rheumatoid arthritis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Liver disease</keyword>
	<keyword>Volatile organic compound</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Oxidative stress</keyword>
	<keyword>non-invasive test</keyword>
</DOC>